Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Supriya Lifescience Ltd

NSE: SUPRIYA · BSE: 543434 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹889.25
Market cap
₹7,157 Cr
Revenue (annual)
₹827.9 Cr
Net profit (annual)
₹209.1 Cr
P/E (TTM)
36.1×Sector 47.3×
Promoter holding
68.30%+0.00% QoQ
FII holding
6.18%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

21:56 IST NSE
Annual General Meeting

Supriya Lifescience Annual General Meeting

Supriya Lifescience Limited conducted its 18th Annual General Meeting on September 24, 2026. All resolutions proposed in the meeting were passed with the requisite majority.

19:49 IST BSE
Annual General Meeting

Supriya Lifescience Annual General Meeting

Supriya Lifescience Ltd has issued the notice for its 18th Annual General Meeting scheduled for September 24, 2026, alongside the Annual Report for FY 2025-26.

13:05 IST BSE
Annual General Meeting

Supriya Lifescience Annual General Meeting

Supriya Lifescience Ltd. shareholders approved the re-appointment of Mr. Balasaheb Sawant as Whole Time Director via postal ballot, as per the voting results.

16:53 IST BSE
Annual General Meeting

Supriya Lifescience Annual General Meeting

Supriya Lifescience Ltd issued a Postal Ballot Notice to shareholders seeking approval for the re-appointment of Mr. Balasaheb Sawant as a Whole Time Director.

15:19 IST NSE
Annual General Meeting

Supriya Lifescience Annual General Meeting

Supriya Lifescience Limited announced the passing of three special resolutions via postal ballot with requisite majority. Shareholders approved the appointments of Mr. Manish Panchal and Mr. Kothandaraman Hari, and the re-appointment of Dr. Neelam Arora, as Non-Executive Independent Directors for five-year terms.

Execution
5 years